Eli Lilly Is on the Warpath, Now Suing Pharmacies and Spas for Selling Compounded Mounjaro

Gizmodo

The arms race over the next generation of obesity drugs is continuing to heat up.

A new class of weight loss drugs is powering massive stock-market gains for Novo Nordisk and Eli Lilly

Tech Insider
Ozempic box
Ozempic.

Getty Images

Makers of Ozempic and Mounjaro Sued Over Allegedly 'Downplaying' Severe Side Effects

Gizmodo

The makers of two popular but off-label weight loss drugs are now being sued over complications allegedly linked to their use. This week, a Louisiana woman filed a complaint against the companies Novo Nordisk and Eli Lilly, arguing that they have misled patients about the risk of severe gastrointestinal side effects…

Medicare is barred from paying for weight-loss drugs like Wegovy. Lawmakers just took the first step to change that.

Tech Insider
Three boxes of Wegovy on a light wood counter

picture alliance/Getty Images

An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly

Tech Insider
A technician looks at a computer screen showing a brain scan.
A brain scan.

BSIP/Universal Images Group via Getty Images

Medicare is prohibited from covering weight-loss drugs — Ozempic could change that

Tech Insider
ozempic pen
Semaglutide is a weekly injection that mimics a hunger-regulating hormone in the body.

Insider

Subscribe to Eli Lilly